期刊文献+

Inhibitory Effects of MicroRNA-34a on Cell Migration and Invasion of Invasive Urothelial Bladder Carcinoma by Targeting Notch1 被引量:10

Inhibitory Effects of MicroRNA-34a on Cell Migration and Invasion of Invasive Urothelial Bladder Carcinoma by Targeting Notch1
暂未订购
导出
摘要 MicroRNAs (miRNAs or miRs) are a class of short, non-coding RNAs that participate in various oncological processes. This study aims to explore the roles of microRNA-34a (miR-34a) in invasive urothelial bladder carcinoma. miR-34a was transfected into bladder cancer cell lines 253J and J82. The miR-34a expression levels in tissues and cells were detected by using qRT-PCR. The Notch1 expression was detected by qRT-PCR and Western blotting. Cell migratory and invasive abilities were measured by Transwell chamber assay. Bioinformatics and luciferase assay were performed to predict and analyze the binding sites between miRNA-34a and Notch1. It was found that there was aberrant expression of miR-34a in bladder cancer tissues. Moreover, we revealed that ectopic expression of miR-34a suppressed cell migration and invasion, while forced expression of Notch1 increased cell migratory and invasive abilities. Finally, we observed that miR-34a transfection significantly down-regulated luciferase activity and reduced the mRNA and protein levels of Notch1. Our study concluded that microRNA-34a antagonizes Notch1 and inhibits cell migration and invasion of bladder cancer cells, which indicates the tumor-suppressive function of microRNA-34a in bladder cancer. MicroRNAs (miRNAs or miRs) are a class of short, non-coding RNAs that participate in various oncological processes. This study aims to explore the roles of microRNA-34a (miR-34a) in invasive urothelial bladder carcinoma. miR-34a was transfected into bladder cancer cell lines 253J and J82. The miR-34a expression levels in tissues and cells were detected by using qRT-PCR. The Notch1 expression was detected by qRT-PCR and Western blotting. Cell migratory and invasive abilities were measured by Transwell chamber assay. Bioinformatics and luciferase assay were performed to predict and analyze the binding sites between miRNA-34a and Notch1. It was found that there was aberrant expression of miR-34a in bladder cancer tissues. Moreover, we revealed that ectopic expression of miR-34a suppressed cell migration and invasion, while forced expression of Notch1 increased cell migratory and invasive abilities. Finally, we observed that miR-34a transfection significantly down-regulated luciferase activity and reduced the mRNA and protein levels of Notch1. Our study concluded that microRNA-34a antagonizes Notch1 and inhibits cell migration and invasion of bladder cancer cells, which indicates the tumor-suppressive function of microRNA-34a in bladder cancer.
出处 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2012年第3期375-382,共8页 华中科技大学学报(医学英德文版)
基金 supported by a grant from the National Natural Science Foundation of China(No.30972982)
关键词 microRNA-34a urothelial carcinoma migration INVASION NOTCH1 microRNA-34a urothelial carcinoma migration invasion Notch1
  • 相关文献

参考文献4

二级参考文献56

  • 1Sorrentino A,Liu CG,Addario A,et al.Role of mi- croRNAs in drug-resistant ovarian cancer cells. Gynecologic Oncology . 2008
  • 2van Jaarsveld MT,Helleman J,Berns EM,et al.Mi- croRNAs in ovarian cancer biology and therapy resis- tance. International Journal of Biochemistry Cell Biology The . 2010
  • 3Ma J,Dong C,Ji C.MicroRNA and drug resistance. Cancer Gene Therapy . 2010
  • 4Jones NA,Turner J,McIlwrath AJ,et al.Cisplatin- and paclitaxel-induced apoptosis of ovarian carcinoma cells and the relationship between bax and bak up-regulation and the functional status of p53. Molecular Pharmacology . 1998
  • 5Legge F,Ferrandina G,Salutari V,et al.Biological char- acterization of ovarian cancer: prognostic and therapeutic implications. Annals of Oncology . 2005
  • 6Reed NS,Sadozye AH.Role of chemotherapy in the management of epithelial ovarian cancer. Expert Review of Anticancer Therapy . 2005
  • 7Ferrandina,G.et al.Class Ⅲ beta-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients. Clinical Cancer Research . 2006
  • 8Zheng T,Wang J,Chen X,Liu L.Role of microRNA in anticancer drug resistance. International Journal of Cancer . 2010
  • 9Yang H,Kong W,He L, etal.MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Research . 2008
  • 10Kobayashi T,Lu J,Cobb BS,Rodda SJ,McMahon AP,Schipani E, et al.Dicer-dependent pathways regulate chondrocyte proliferation and differentiation. Proceedings of the National Academy of Sciences of the United States of America . 2008

共引文献81

同被引文献9

引证文献10

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部